Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. It also offers comprehensive contract research organization (CRO) solutions, including one-stop, full-process services for drug R&D, such as Phase I to IV clinical trials, bioequivalence and pharmacokinetics testing, medical science services, R&D project consulting, data management and statistical services, and third-party testing, which covers bioanalytical testing, packaging material compatibility, compound structure confirmation, quality studies, and base toxic impurity analysis. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021. Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd was founded in 1959 and is based in Urumqi, China.
Research context
Xinjiang Baihuacun Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Consumer Cyclical
- Industry
- Restaurants
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Xinjiang Baihuacun Co., Ltd is currently in a long term uptrend where the price is trading 30.6% above its 200 day moving average.
From a valuation standpoint, the stock is 218.8% more expensive than other stocks from the Consumer Cyclical sector with a price to sales ratio of 16.4.
Xinjiang Baihuacun Co., Ltd's total revenue sank by 95.1% to $3M since the same quarter in the previous year.
Its net income has dropped by 1699.3% to $-278M since the same quarter in the previous year.
Finally, its free cash flow fell by 257.2% to $-31M since the same quarter in the previous year.
Based on the above factors, Xinjiang Baihuacun Co., Ltd gets an overall score of 1/5.